TANEZUMAB
UNII EQL0E9GCX1

Substance Identification & Data

This profile provides standardized clinical and technical data for Tanezumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) EQL0E9GCX1.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 880266-57-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

EQL0E9GCX1

CAS Registry Number

880266-57-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TANEZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C71522

National Cancer Institute reference terminology for clinical and research data.

INN ID

8941

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

SS-111

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tanezumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TANEZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G2, ANTI (HUMAN NERVE GROWTH FACTOR) (HUMAN MOUSE MONOCLONAL RN624 HEAVY CHAIN), DISULFIDE WITH HUMAN MOUSE MONOCLONAL RN624 LIGHT CHAIN, DIMER

IMMUNOGLOBULIN G2, ANTI (HUMAN NERVE GROWTH FACTOR) (HUMAN MOUSE MONOCLONAL RN624 HEAVY CHAIN), DISULPHIDE WITH HUMAN MOUSE MONOCLONAL RN624 LIGHT CHAIN, DIMER

TANEZUMAB [INN]

TANEZUMAB [JAN]

TANEZUMAB [USAN]

TANEZUMAB [WHO-DD]